SCHEMBL3265653

SCHEMBL3265653

O=C(NCCCN1CCN(c2ccc3ncccc3c2)CC1)c1cc[nH]c1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 3/20 0.67
HTR2A P28223 2/20 0.67
HTR1A P08908 1/20 0.67
ADRA2A P08913 1/20 0.67
ADRA2B P18089 1/20 0.67
ADRA2C P18825 1/20 0.67
ADRA1D P25100 1/20 0.67
ADRA1A P35348 1/20 0.67
HRH1 P35367 1/20 0.67
ADRA1B P35368 1/20 0.67
KCNH2 Q12809 1/20 0.67
DRD2 P14416 1/20 0.58
SLC6A4 P31645 4/20 0.52
HTR2C P28335 1/20 0.51
SLC6A2 P23975 1/20 0.51
HTR7 P34969 2/20 0.49
HTR6 P50406 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3265484 0.81 HTR2A (0.60) DRD3HTR2AHTR1ADRD2SLC6A4
SCHEMBL1039928 0.80 DRD3 (1.00) DRD3HTR2AHTR1AADRA2AADRA2B
SCHEMBL2214899 0.78 HTR2A (0.70) DRD3HTR2AHTR1AADRA2AADRA2B
SCHEMBL3268873 0.77 DRD2 (0.55) DRD3HTR2AHTR1ADRD2HTR2C
SCHEMBL2213700 0.77 HTR2A (0.74) DRD3HTR2AHTR1AADRA2AADRA2B
SCHEMBL2213871 0.77 HTR2A (0.66) DRD3HTR2AHTR1AADRA2AADRA2B
SCHEMBL2214238 0.76 HTR2A (0.65) DRD3HTR2AHTR1AADRA2AADRA2B
SCHEMBL4519092 0.74 DRD3 (1.00) DRD3HTR2AHTR1AADRA2AADRA2B
SCHEMBL13398528 0.74 HTR2A (0.54) DRD3HTR2AHTR1AADRA2AADRA2B
SCHEMBL13399005 0.73 DRD3 (0.51) DRD3HTR2AHTR1AADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010038948-A2 ARYLPIPERAZINE-CONTAINING PYRROLE 3-CARBOXAMIDE DERIVATIVES FOR TREATING DEPRESSIVE DISORDERS GREEN CROSS CORPORATION (KR) 2010-04-08 WO disclosed